Published in J Clin Psychiatry on April 01, 2004
Psychiatric comorbidities and schizophrenia. Schizophr Bull (2008) 2.69
Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings. J Neurodev Disord (2012) 1.73
Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder. NeuroRx (2006) 1.43
Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders. BMC Psychiatry (2014) 1.39
Advances in the treatment of depression. NeuroRx (2006) 1.03
Assessing the validity of current mouse genetic models of obsessive-compulsive disorder. Behav Pharmacol (2009) 0.96
Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762]. BMC Psychiatry (2005) 0.89
Physician patterns of metabolic screening for patients taking atypical antipsychotics: a retrospective database study. Prim Care Companion J Clin Psychiatry (2006) 0.84
Current trends in drug treatment of obsessive-compulsive disorder. Neuropsychiatr Dis Treat (2010) 0.84
Emerging targets for antidepressant therapies. Curr Opin Chem Biol (2009) 0.82
Atypical antipsychotic augmentation in SSRI treatment refractory obsessive-compulsive disorder: a systematic review and meta-analysis. BMC Psychiatry (2014) 0.82
Clinical treatment of obsessive compulsive disorder. Psychiatry (Edgmont) (2005) 0.81
Antipsychotic Augmentation of Serotonin Reuptake Inhibitors in Treatment-Resistant Obsessive-Compulsive Disorder: An Update Meta-Analysis of Double-Blind, Randomized, Placebo-Controlled Trials. Int J Neuropsychopharmacol (2015) 0.80
Novel targets for antidepressant therapies. Curr Psychiatry Rep (2008) 0.80
D2 and D3 dopamine receptor affinity predicts effectiveness of antipsychotic drugs in obsessive-compulsive disorders: a metaregression analysis. Psychopharmacology (Berl) (2014) 0.77
Molecular mechanisms underlying synergistic effects of SSRI-antipsychotic augmentation in treatment of negative symptoms in schizophrenia. J Neural Transm (Vienna) (2009) 0.76
An emerging role for escitalopram in the treatment of obsessive-compulsive disorder. Neuropsychiatr Dis Treat (2007) 0.76
Aripiprazole augmentation of combination escitalopram and sertraline in the treatment of refractory obsessive-compulsive disorder. Psychiatry (Edgmont) (2005) 0.75
Advances in the Management of Treatment-Resistant Depression. Focus (Am Psychiatr Publ) (2010) 0.75
Should psychiatrists use atypical antipsychotics to treat nonpsychotic anxiety? Psychiatry (Edgmont) (2009) 0.75
Assessment and management of treatment-refractory obsessive-compulsive disorder in children. J Am Acad Child Adolesc Psychiatry (2015) 0.75
Augmentation of olanzapine in treatment-resistant schizophrenia. J Psychiatry Neurosci (2005) 0.75
Atypical antipsychotics for mood and anxiety disorders: safe and effective adjuncts? J Psychiatry Neurosci (2005) 0.75
Current management of obsessive and phobic states. Neuropsychiatr Dis Treat (2011) 0.75
Pharmacotherapy response and regional cerebral blood flow characteristics in patients with obsessive-compulsive disorder. Behav Brain Funct (2013) 0.75
Cognitive behavioral therapy in pharmacoresistant obsessive-compulsive disorder. Neuropsychiatr Dis Treat (2016) 0.75
Prefrontal cortex activation during neuropsychological tasks might predict response to pharmacotherapy in patients with obsessive-compulsive disorder. Neuropsychiatr Dis Treat (2017) 0.75
Brain metabolic changes during cigarette craving. Arch Gen Psychiatry (2002) 3.16
Cerebral glucose metabolism in obsessive-compulsive hoarding. Am J Psychiatry (2004) 2.40
Mindfulness meditation training in adults and adolescents with ADHD: a feasibility study. J Atten Disord (2007) 2.13
Gene variants of brain dopamine pathways and smoking-induced dopamine release in the ventral caudate/nucleus accumbens. Arch Gen Psychiatry (2006) 2.00
Hoarding disorder: a new diagnosis for DSM-V? Depress Anxiety (2010) 2.00
Refining the diagnostic boundaries of compulsive hoarding: a critical review. Clin Psychol Rev (2010) 1.68
Is compulsive hoarding a genetically and neurobiologically discrete syndrome? Implications for diagnostic classification. Am J Psychiatry (2007) 1.58
Attenuation of cue-induced cigarette craving and anterior cingulate cortex activation in bupropion-treated smokers: a preliminary study. Psychiatry Res (2004) 1.55
Ventral striatal dopamine release in response to smoking a regular vs a denicotinized cigarette. Neuropsychopharmacology (2008) 1.49
Obsessive-compulsive disorder: a review of the diagnostic criteria and possible subtypes and dimensional specifiers for DSM-V. Depress Anxiety (2010) 1.47
Paroxetine treatment of compulsive hoarding. J Psychiatr Res (2006) 1.43
Differential brain metabolic predictors of response to paroxetine in obsessive-compulsive disorder versus major depression. Am J Psychiatry (2003) 1.40
Obsessive-compulsive hoarding: symptom severity and response to multimodal treatment. J Clin Psychiatry (2002) 1.39
Thoughts of feral cat control. J Am Vet Med Assoc (2010) 1.38
Age at onset and clinical features of late life compulsive hoarding. Int J Geriatr Psychiatry (2010) 1.36
Differential cerebral metabolic changes with paroxetine treatment of obsessive-compulsive disorder vs major depression. Arch Gen Psychiatry (2002) 1.30
Should an obsessive-compulsive spectrum grouping of disorders be included in DSM-V? Depress Anxiety (2010) 1.15
Prenatal diagnosis of Down syndrome: a systematic review of termination rates (1995-2011). Prenat Diagn (2012) 1.12
Differential efficacy of memantine for obsessive-compulsive disorder vs. generalized anxiety disorder: an open-label trial. Psychopharmacol Bull (2009) 1.08
Cognitive-behavioral therapy for geriatric compulsive hoarding. Behav Res Ther (2011) 1.08
Effect of a history of major depressive disorder on smoking-induced dopamine release. Biol Psychiatry (2009) 1.03
Refractory obsessive-compulsive disorder: state-of-the-art treatment. J Clin Psychiatry (2002) 1.03
Executive functioning in older adults with hoarding disorder. Int J Geriatr Psychiatry (2013) 0.89
Quality of life and functional impairment in compulsive hoarding. J Psychiatr Res (2010) 0.87
The pathophysiology of body dysmorphic disorder. Body Image (2008) 0.86
Treatment of compulsive hoarding. J Clin Psychol (2004) 0.85
Therapist and patient perspectives on cognitive-behavioral therapy for older adults with hoarding disorder: a collective case study. Aging Ment Health (2012) 0.84
Faculty development initiatives to advance research literacy and evidence-based practice at CAM academic institutions. J Altern Complement Med (2014) 0.84
Obsessive-compulsive disorder: boundary issues. CNS Spectr (2007) 0.83
St John's wort versus placebo in obsessive-compulsive disorder: results from a double-blind study. Int Clin Psychopharmacol (2005) 0.82
Effects of intensive cognitive-behavioral therapy on cingulate neurochemistry in obsessive-compulsive disorder. J Psychiatr Res (2013) 0.81
A prospective patient-centered data collection program at an acupuncture and oriental medicine teaching clinic. J Altern Complement Med (2012) 0.81
A pilot controlled trial of bupropion XL versus escitalopram in generalized anxiety disorder. Psychopharmacol Bull (2008) 0.80
AcuTrials®: an online database of randomized controlled trials and systematic reviews of acupuncture. BMC Complement Altern Med (2013) 0.77
Acupuncture and in vitro fertilization: a retrospective chart review. J Altern Complement Med (2013) 0.76
Quetiapine augmentation in obsessive-compulsive disorder resistant to serotonin reuptake inhibitors: an open-label study. J Clin Psychiatry (2005) 0.76
Predicting treatment response in obsessive-compulsive disorder. J Neuropsychiatry Clin Neurosci (2002) 0.75
Secondary obsessive-compulsive disorder related to diaschisis after pontine infarction, successfully treated with paroxetine. Psychiatry Clin Neurosci (2007) 0.75